Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Acute Myeloid Leukemia
100%
Philadelphia Chromosome
100%
AMN107
100%
Rare Translocations
100%
46,XY
85%
Imatinib
57%
Lack of Response
42%
Bone Marrow Aspirate
42%
Imatinib Mesylate
42%
PTK787
42%
High Dose
28%
Bone Marrow
28%
High-dose Ara-C
28%
Lamb
28%
Pancytopenia
28%
Caspofungin
28%
Hematological Response
28%
Blast Analysis
28%
Inv(9)
28%
Topoisomerase Inhibitors
14%
Quantitative PCR
14%
Tyrosine Kinase Inhibitor
14%
Poor Prognosis
14%
Chemotherapy
14%
Complete Remission
14%
Chronic Myeloid Leukemia
14%
Lung
14%
Leukocytes
14%
Transfusion
14%
Dysplasia
14%
Hydroxyurea
14%
Cytarabine
14%
Concomitant Treatment
14%
Idarubicin
14%
Adverse Events
14%
Broad-spectrum Antibiotics
14%
Antifungal Therapy
14%
Fludarabine
14%
Young Males
14%
Ara-C
14%
Kinase Inhibitor
14%
Antibiotic Treatment
14%
Mitoxantrone
14%
BCR-ABL1
14%
Fine-needle Aspiration Biopsy
14%
Male Patients
14%
Karyotype Analysis
14%
Fluorescence in Situ Hybridization
14%
Cytogenetic Analysis
14%
Suberoylanilide Hydroxamic Acid
14%
Bone Marrow Examination
14%
Blast Phase
14%
ABL1
14%
Mucormycosis
14%
Ph Chromosome
14%
Fusion Signal
14%
Double Fusion
14%
Tasigna
14%
Letter to Editor
14%
Myeloid Blast
14%
Failed Therapy
14%
Medicine and Dentistry
Acute Myeloid Leukemia
100%
P21
100%
Philadelphia 1 Chromosome
100%
Nilotinib
100%
Imatinib
87%
Drug Megadose
50%
Cytarabine
50%
Vatalanib
37%
Pancytopenia
25%
Caspofungin
25%
Treatment Response
12%
Outpatient
12%
Vorinostat
12%
Interphase
12%
Adverse Event
12%
Dysplasia
12%
Hydroxyurea
12%
Real Time Polymerase Chain Reaction
12%
Antibiotic Therapy
12%
Lung Biopsy
12%
Tyrosine-Kinase Inhibitor
12%
Fine-Needle Aspiration
12%
Chromosome Analysis
12%
Fludarabine
12%
Phosphotransferase Inhibitor
12%
Chronic Myelogenous Leukemia
12%
Amphotericin
12%
Mitoxantrone
12%
Broad-Spectrum Antibiotic
12%
Fluorescence in Situ Hybridization
12%
Metaphase
12%
Gyrase Inhibitor
12%
Antifungal Agent
12%
Amphotericin B
12%
Bone Marrow Examination
12%
Antifungal Therapy
12%
Idarubicin
12%
Mucormycosis
12%
Leukocyte Transfusion
12%
Chemotherapy
12%
Chromosome
12%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Myeloid Leukemia
100%
Nilotinib
100%
Philadelphia 1 Chromosome
100%
Imatinib
87%
Cytarabine
50%
Vatalanib
37%
Pancytopenia
25%
Caspofungin
25%
Protein Tyrosine Kinase Inhibitor
12%
Remission
12%
Vorinostat
12%
Adverse Event
12%
Dysplasia
12%
Hydroxycarbamide
12%
Idarubicin
12%
Gyrase Inhibitor
12%
Phosphotransferase Inhibitor
12%
Amphotericin B
12%
Fludarabine
12%
Chronic Myeloid Leukemia
12%
Chemotherapy Regimens
12%
Antifungal Agent
12%
Mitoxantrone
12%
Mucormycosis
12%
Amphotericin
12%
Antimicrobial Agent
12%
Nursing and Health Professions
Vatalanib
37%
Caspofungin
25%
Bone Marrow Examination
12%
Leukocyte Transfusion
12%
Mitoxantrone
12%
Vorinostat
12%
Phosphotransferase Inhibitor
12%